4.6 Article

The First Case of Ischemia-Free Kidney Transplantation in Humans

期刊

FRONTIERS IN MEDICINE
卷 6, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fmed.2019.00276

关键词

kidney transplantation; ischemia-reperfusion injury; normothermic machine perfusion; ischemia-free kidney transplantation; ischemia-free organ transplantation

资金

  1. National Natural Science Foundation of China [81373156, 81471583, 81570587, 81871257]
  2. Special Fund for Science Research by Ministry of Health [201302009]
  3. Key Clinical Specialty Construction Project of National Health and Family Planning Commission of the People's Republic of China
  4. Guangdong Provincial Key Laboratory Construction Projection on Organ Donation and Transplant Immunology [2013A061401007]
  5. Guangdong Provincial International Cooperation Base of Science and Technology (Organ Transplantation) [2015B050501002]
  6. Guangdong Provincial Natural Science Funds for Major Basic Science Culture Project [2015A030308010, 2018A030313612]
  7. Guangdong Provincial Natural Science Funds for Distinguished Young Scholars [2015A030306025]
  8. Special Support Program for Training High-Level Talents in Guangdong Province [2015TQ01R168]
  9. Pearl River Nova Program of Guangzhou [201506010014]
  10. Science and Technology Program of Guangzhou [201704020150]

向作者/读者索取更多资源

Background: Ischemia-reperfusion injury (IRI) has been considered an inevitable event in organ transplantation since the first successful kidney transplant was performed in 1954. To avoid IRI, we have established a novel procedure called ischemia-free organ transplantation. Here, we describe the first case of ischemia-free kidney transplantation (IFKT). Materials and Methods: The kidney graft was donated by a 19-year-old brain-dead donor. The recipient was a 47-year-old man with end-stage diabetic nephropathy. The graft was procured, preserved, and implanted without cessation of blood supply using normothermic machine perfusion. Results: The graft appearance, perfusion flow, and urine production suggested that the kidney was functioning well-during the whole procedure. The creatinine dropped rapidly to normal range within 3 days post-transplantation. The levels of serum renal injury markers were low post-transplantation. No rejection or vascular or infectious complications occurred. The patient had an uneventful recovery. Conclusion: This paper marks the first case of IFKT in humans. This innovation may offer a unique solution to optimizing transplant outcomes in kidney transplantation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据